Literature DB >> 24562840

A systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions.

L Si1, T M Winzenberg, B de Graaff, A J Palmer.   

Abstract

This study aimed to statistically combine multiple health state utility values (HSUVs) reported in the literature for patients with osteoporosis and osteoporotic fractures. Fracture events were associated with decrements in HSUVs which differed between fracture sites. We have provided summary values for use in future health economics analyses in osteoporosis. Osteoporotic fractures have high financial and health burden. Economic evaluations on osteoporotic fracture prevention have been frequently performed in past decades. One of the challenges in the economic evaluations was to identify consistent health state utility values (HSUVs) to use for osteoporotic fracture-related conditions. The objective of this study was to determine summary measures of multiple HSUVs reported in the literature for patients with osteoporosis and osteoporotic fractures. We performed a systematic review, meta-analysis and meta-regression of published literature that reported HSUVs for osteoporotic fracture-related conditions. There were 62 studies representing 142,477 patients included. In total, 362 HSUVs were identified: 106 for pre-fracture; 89 for post-hip fracture; 130 for post-vertebral fracture and 37 for post-wrist fracture. The pooled HSUVs, using a random-effects model were 0.76 (95% CI 0.75, 0.77, I (2) = 0.99) for pre-fracture; 0.57 (95% CI 0.52, 0.63, I (2) =1) for post-hip fracture; 0.59 (95% CI 0.55, 0.62, I (2) = 0.99) for post-vertebral facture and 0.72 (95% CI 0.67, 0.78, I (2) = 1) for post-wrist fracture. Heterogeneities were addressed through meta-regression. HSUVs immediately following hip, vertebral and wrist fractures were 0.31, 0.44 and 0.61, respectively. Patients' HSUVs improved over time following fracture events: HSUVs for the first year after hip, vertebral and wrist fractures were 0.59, 0.55 and 0.78, respectively; and 0.66, 0.66 and 0.81 for subsequent years. Fractures were associated with significant decrements in HSUVs. This study provides a standard set of HSUVs that can be used in health economic assessments in osteoporosis.

Entities:  

Mesh:

Year:  2014        PMID: 24562840     DOI: 10.1007/s00198-014-2636-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group.

Authors:  J A Berlin
Journal:  Lancet       Date:  1997-07-19       Impact factor: 79.321

4.  Gender differences in multiple underlying dimensions of health-related quality of life are associated with sociodemographic and socioeconomic status.

Authors:  Dasha Cherepanov; Mari Palta; Dennis G Fryback; Stephanie A Robert; Ron D Hays; Robert M Kaplan
Journal:  Med Care       Date:  2011-11       Impact factor: 2.983

Review 5.  Missing data analysis using multiple imputation: getting to the heart of the matter.

Authors:  Yulei He
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-01

6.  A comparison of the EQ-5D and SF-6D across seven patient groups.

Authors:  John Brazier; Jennifer Roberts; Aki Tsuchiya; Jan Busschbach
Journal:  Health Econ       Date:  2004-09       Impact factor: 3.046

7.  Health-related quality of life and radiographic vertebral fracture.

Authors:  W Cockerill; M Lunt; A J Silman; C Cooper; P Lips; A K Bhalla; J B Cannata; R Eastell; D Felsenberg; C Gennari; O Johnell; J A Kanis; C Kiss; P Masaryk; M Naves; G Poor; H Raspe; D M Reid; J Reeve; J Stepan; C Todd; A D Woolf; T W O'Neill
Journal:  Osteoporos Int       Date:  2003-11-13       Impact factor: 4.507

8.  The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture.

Authors:  F Borgström; I Lekander; M Ivergård; O Ström; A Svedbom; V Alekna; M L Bianchi; P Clark; M D Curiel; H P Dimai; M Jürisson; R Kallikorm; O Lesnyak; E McCloskey; E Nassonov; K M Sanders; S Silverman; M Tamulaitiene; T Thomas; A N A Tosteson; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2013-01-10       Impact factor: 4.507

Review 9.  Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Authors:  E Hernlund; A Svedbom; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

Review 10.  A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments.

Authors:  Melanie Wyld; Rachael Lisa Morton; Andrew Hayen; Kirsten Howard; Angela Claire Webster
Journal:  PLoS Med       Date:  2012-09-11       Impact factor: 11.069

View more
  43 in total

1.  Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.

Authors:  T Imai; S Tanaka; K Kawakami; T Miyazaki; H Hagino; M Shiraki
Journal:  Osteoporos Int       Date:  2017-03-06       Impact factor: 4.507

2.  Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.

Authors:  T Mori; C J Crandall; D A Ganz
Journal:  Osteoporos Int       Date:  2017-02-17       Impact factor: 4.507

3.  Quality of life, resource use, and costs related to hip fracture in Estonia.

Authors:  M Jürisson; H Pisarev; J Kanis; F Borgström; A Svedbom; R Kallikorm; M Lember; A Uusküla
Journal:  Osteoporos Int       Date:  2016-02-23       Impact factor: 4.507

4.  Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.

Authors:  B Stollenwerk; T Bartmus; F Klug; S Stock; D Müller
Journal:  Osteoporos Int       Date:  2015-01-09       Impact factor: 4.507

5.  Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.

Authors:  L Si; T M Winzenberg; Q Jiang; A J Palmer
Journal:  Osteoporos Int       Date:  2015-01-08       Impact factor: 4.507

6.  Surgery alters parameters of vitamin D status and other laboratory results.

Authors:  N Binkley; D Coursin; D Krueger; P Iglar; J Heiner; R Illgen; M Squire; J Lappe; P Watson; K Hogan
Journal:  Osteoporos Int       Date:  2016-11-08       Impact factor: 4.507

7.  Social inequality and fractures-secular trends in the Danish population: a case-control study.

Authors:  L Hansen; A Judge; M K Javaid; C Cooper; P Vestergaard; B Abrahamsen; N C Harvey
Journal:  Osteoporos Int       Date:  2018-06-26       Impact factor: 4.507

8.  Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.

Authors:  A Svedbom; F Borgstöm; E Hernlund; O Ström; V Alekna; M L Bianchi; P Clark; M D Curiel; H P Dimai; M Jürisson; R Kallikorm; M Lember; O Lesnyak; E McCloskey; K M Sanders; S Silverman; A Solodovnikov; M Tamulaitiene; T Thomas; N Toroptsova; A Uusküla; A N A Tosteson; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2017-12-11       Impact factor: 4.507

9.  Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study.

Authors:  G Valentin; K Friis; C P Nielsen; F B Larsen; B L Langdahl
Journal:  Osteoporos Int       Date:  2020-07-17       Impact factor: 4.507

10.  Projection of osteoporosis-related fractures and costs in China: 2010-2050.

Authors:  L Si; T M Winzenberg; Q Jiang; M Chen; A J Palmer
Journal:  Osteoporos Int       Date:  2015-03-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.